In 2023, the mortality rate for liver malignant neoplasms among females in the US stood at an estimated value close to the projections for 2024, where it is set to be 10.53 thousand female deaths. The forecast data predicts a year-on-year increase in mortality rates, with 2025 experiencing a 2.19% rise, 2026 a 2.14% increase, 2027 a 2.09% uplift, and 2028 a 1.96% growth. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is projected to be approximately 2.1% per year.
Future trends to watch for include advancements in medical treatments, early detection methods, and prevention strategies, all of which could significantly impact the mortality rates of liver malignant neoplasms. Additionally, public health policies and lifestyle changes among the population may alter future forecasts, potentially slowing the current upward trend.
